134 related articles for article (PubMed ID: 33254500)
1. Bone biology and COVID-19 infection: Is ACE2 a potential influence factor?
Tao H; Bai J; Zhang W; Zheng K; Guan P; Ge G; Li M; Geng D
Med Hypotheses; 2020 Nov; 144():110178. PubMed ID: 33254500
[TBL] [Abstract][Full Text] [Related]
2. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
3. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
[TBL] [Abstract][Full Text] [Related]
4. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
Rezaei M; Ziai SA; Fakhri S; Pouriran R
J Cell Physiol; 2021 Apr; 236(4):2430-2442. PubMed ID: 32901940
[TBL] [Abstract][Full Text] [Related]
5. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
6. ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.
Azizan E; Brown M
Malays J Pathol; 2020 Dec; 42(3):363-367. PubMed ID: 33361716
[TBL] [Abstract][Full Text] [Related]
7. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.
Li FF; Zhang Q; Wang GY; Liu SL
Aging (Albany NY); 2020 Nov; 12(21):20938-20945. PubMed ID: 33186121
[TBL] [Abstract][Full Text] [Related]
9. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
10. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity.
Hammoud SH; Wehbe Z; Abdelhady S; Kobeissy F; Eid AH; El-Yazbi AF
Mol Pharmacol; 2021 Jan; 99(1):17-28. PubMed ID: 33082267
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.
Mariappan V; S R R; Balakrishna Pillai A
IUBMB Life; 2020 Dec; 72(12):2533-2545. PubMed ID: 33031602
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
14. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
15. Dysimmunity and inflammatory storm: Watch out for bone lesions in COVID-19 infection.
Tao H; Ge G; Li W; Liang X; Wang H; Li N; Sun H; Zhang W; Geng D
Med Hypotheses; 2020 Dec; 145():110332. PubMed ID: 33039950
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?
Wiese OJ; Allwood BW; Zemlin AE
Med Hypotheses; 2020 Nov; 144():110231. PubMed ID: 33254538
[TBL] [Abstract][Full Text] [Related]
17. Relationship between COVID-19 and the male reproductive system.
Meng TT; Dong RJ; Li TG
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1109-1113. PubMed ID: 33577068
[TBL] [Abstract][Full Text] [Related]
18. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
